Cellyrix Therapeutics Revenue

Biotechnology Research • • 1-10 Employees

Cellyrix Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Cellyrix Therapeutics

Eran Kotler

Co-Founder & CEO

Company overview

Headquarters	XX
NAICS	541714
Employees	1-10

About Cellyrix Therapeutics

At Cellyrix, we are on a mission to introduce a new paradigm for cancer treatment by harnessing the power of cutting-edge technologies. Tumor heterogeneity, a fundamental aspect of cancer, lies at the heart of treatment challenges such as therapy resistance, metastasis, and relapse. Leveraging breakthroughs in single-cell sequencing and artificial intelligence, we are pioneering a novel approach to unlock insights into intra-tumor heterogeneity and develop innovative cancer treatments.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Cellyrix Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Cellyrix Therapeutics has never raised funding before.

Frequently asked questions

Cellyrix Therapeutics is located in XX.

Cellyrix Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Cellyrix Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Cellyrix Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Cellyrix Therapeutics

Eran Kotler

Co-Founder & CEO

4.8

40,000 users